US Stock MarketDetailed Quotes

GNFT Genfit

Watchlist
  • 3.660
  • +0.160+4.57%
Close May 3 16:00 ET
182.49MMarket Cap-5865P/E (TTM)

About Genfit Company

Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver. The company was founded by Jean-Fran?ois Mouney, Florence Séjourné, and Bart Staels in September 1999 and is headquartered in Loos, France.

Company Profile

SymbolGNFT
Company NameGenfit
Listing DateMar 27, 2019
Issue Price20.32
Founded1999
CEOMr. Pascal Prigent
MarketNASDAQ
Employees159
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressParc Eurasante,885, Avenue Eugène Avinée,Lille Métropole
CityLoos
ProvinceHF
CountryFrance
Zip Code59120
Phone33-3-20-16-40-00

Company Executives

  • Name
  • Position
  • Salary
  • Pascal Prigent
  • Chief Executive Officer
  • 632.43K
  • Stefanie Magner
  • Chief Compliance Officer and Executive Vice President, International Legal Affairs
  • --
  • Dr. Meriam Kabbaj, PhD
  • Chief Technology Officer
  • --
  • Thomas Baetz
  • Chief Financial Officer
  • --
  • Dean Hum, PhD
  • Chief Scientific Officer
  • --
  • Jean-Christophe Marcoux
  • Chief Corporate Affairs Officer, Head of Investor Relations and Head of ESG
  • --
  • Pascal Caisey
  • Chief Operating Officer
  • --
  • Carol Addy
  • Chief Medical Officer
  • --
  • Tom Huijbers
  • Executive Vice President, Regulatory
  • --
  • Emilie Desodt
  • Executive Vice President, Human Resources
  • --
  • John Brozek
  • Executive Vice President, Data and Information Technology
  • --
  • Sayah-Jeanne Sakina
  • Executive Vice President, Research and Translational Science
  • --
  • Jean-Francois Mouney
  • Chairman of the Board
  • 368.55K
  • Xavier Guille des Buttes
  • Vice Chairman of the Board
  • 96.25K
  • Laurent Lannoo
  • Corporate Secretary and Director of Legal Affairs
  • --
  • Sandra Silvestri
  • Director
  • --
  • Florence Sejourne
  • Director
  • --
  • Jean-Francois Tine
  • Independent Director
  • 43.75K
  • Anne-Helene Monsellato
  • Independent Director
  • 52.50K
  • Katherine Bach Kalin, M.B.A.
  • Independent Director
  • 46.25K
  • Eric Baclet
  • Independent Director
  • 60.00K
  • Dr. Catherine Larue, PhD
  • Independent Director
  • 53.13K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg